One Cancer Voice statement on 10-year cancer plan
Published on: 30 March 2022In collaboration with over 50 cancer charities, we have published a consensus statement in response to the Government’s Call for Evidence to inform a new 10-year Cancer Plan.
We believe that people living with cancer must be at the heart of cancer care and support and they should be involved in their care and decisions about their treatment and the development of cancer services.
If the new 10-year Cancer Plan is to be successful in delivering world leading and transformative change then we believe it must meet the following 10 tests:
- The 10-year Cancer Plan has clear political leadership, is fully costed and funded throughout its lifetime, with an annual report published on progress made against its ambitions.
- More cancers are prevented, with awareness raised of the risks and causes of cancer.
- The public is aware of the risk factors, signs and symptoms of cancer and act on them, leading to improvements in presentation. Emergency presentation is reduced to no more than 5%.
- Progress towards early diagnosis is accelerated so that 78% of people are diagnosed at stage one or stage two and a 95% Faster Diagnosis Standard is met.
- Every person with cancer can access the treatment they need, at the right time, for the best outcomes. Cancer Waiting Time targets are met in every part of the country.
- By 2032, everyone with cancer is able to access a needs assessment and personalised care plan to support their health and wider wellbeing needs.
- Workforce and equipment shortages are addressed so that every person with cancer has access to the specialist workforce they need when they need it.
- Cases of cancer attributable to inequalities have meaningfully decreased.
- Clinical research capacity is increased, health service staff have access to dedicated research time and training and all populations are given the opportunity to participate in clinical trials.
- Data collection is timely, accessible, standardised and comprehensive and it is analysed and published swiftly to support the delivery and monitoring of all aspects of cancer across the pathway and cancer research.
The pandemic has affected cancer care and there is an urgent need to level up by focusing on inequalities across the cancer pathway so that everyone gets the very best cancer care.